CD20-positive Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch CD20-positive Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL" (NCT04920968) | Maria Sklodowska-Curie National Research Institute of Oncology | 2021-10-05 |
Track CD20-positive Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.